Home » Topics » Conferences

Conferences
RSS

Team from Angiotech demonstrates paclitaxel's potential as an antipsoriatic

Nov. 12, 1998

S-18127 characterized as a selective, structurally novel 5-HT1B/1D receptor antagonist

Nov. 12, 1998

Levosimendan clinical results presented this week at AHA meeting

Nov. 12, 1998

Radiopharmaceutical for chronic knee synovitis in development at British university

Nov. 11, 1998

Cytel's VLA4 antagonist shows potential for treating allergic lung inflammation

Nov. 11, 1998

Inhibition of cytokine production contributes to the antiinflammatory activity of orazipone

Nov. 11, 1998

Photoangioplasty with Antrin reduces atherosclerotic plaque in rabbit models

Nov. 11, 1998

Neuroprotective effects of NCC-161, a new neuronal calcium antagonist

Nov. 11, 1998

Synthelabo presents new 5-HT1A inverse agonist with antagonist and anxiolytic-like activity in vivo

Nov. 11, 1998

PD-161989: novel AMPA/GLYN receptor antagonist related to PNQX

Nov. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...